NeuroD1 regulates survival and migration of neuroendocrine lung carcinomas via signaling molecules TrkB and NCAM

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 16, 2013, Pages 6524-6529

  Osborne, Jihan K ^a   Larsen, Jill E ^b   Shields, Misty D ^b   Gonzales, Joshua X ^a   Shames, David S ^b,d   Sato, Mitsuo ^b,e   Kulkarni, Ashwinikumar ^a,f   Wistuba, Ignacio I ^c   Girard, Luc ^a,b   Minna, John D ^a,b   Cobb, Melanie H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d GENENTECH INC   (United States)

^e NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; LESTAURTINIB; NERVE CELL ADHESION MOLECULE; NEUROGENIC DIFFERENTIATION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER SURVIVAL; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; MOLECULAR INTERACTION; MOUSE; NERVE CELL DIFFERENTIATION; NEUROENDOCRINE TUMOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TUMOR DIFFERENTIATION;

ANALYSIS OF VARIANCE; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARBAZOLES; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LUCIFERASES; LUNG NEOPLASMS; MICE; MICROARRAY ANALYSIS; NEURAL CELL ADHESION MOLECULES; PLASMIDS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, TRKB; SMALL CELL LUNG CARCINOMA;

EID: 84876205922     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1303932110     Document Type: Article

References (47)

1. Fischer B, Arcaro A (2008) Current status of clinical trials for small cell lung cancer. Rev Recent Clin Trials 3(1):40-61.
2. Jackman DM, Johnson BE (2005) Small-cell lung cancer. Lancet 366(9494):1385-1396.
3. Sato M, Shames DS, Gazdar AF, Minna JD (2007) Atranslational view of the molecular pathogenesis of lung cancer. J Thorac Oncol 2(4):327-343.
4. Sun S, Schiller JH, Spinola M, Minna JD (2007) New molecularly targeted therapies for lung cancer. J Clin Invest 117(10):2740-2750.
5. Radice PA, et al. (1982) The clinical behavior of "mixed" small cell/large cell bronchogenic carcinoma compared to "pure" small cell subtypes. Cancer 50(12):2894-2902.
6. Ionescu DN, et al. (2007) Nonsmall cell lung carcinoma with neuroendocrine differentiation-an entity of no clinical or prognostic significance. Am J Surg Pathol 31(1): 26-32.
7. Miyata T, Maeda T, Lee JE (1999) NeuroD is required for differentiation of the granule cells in the cerebellum and hippocampus. Genes Dev 13(13):1647-1652.
8. Naya FJ, Stellrecht CM, Tsai MJ (1995) Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. Genes Dev 9(8):1009-1019.
9. Malecki MT, et al. (1999) Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet 23(3):323-328.
10. Abrahamsson PA (1999) Neuroendocrine differentiation in prostatic carcinoma. Prostate 39(2):135-148.
11. Cantile M, et al. (2005) cAMP induced modifications of HOX D gene expression in prostate cells allow the identification of a chromosomal area involved in vivo with neuroendocrine differentiation of human advanced prostate cancers. J Cell Physiol 205(2):202-210.
12. Cindolo L, et al. (2007) NeuroD1 expression in human prostate cancer: Can it contribute to neuroendocrine differentiation comprehension? Eur Urol 52(5):1365-1373.
13. Fratticci A, et al. (2007) Differential expression of neurogenins and NeuroD1 in human pituitary tumours. J Endocrinol 194(3):475-484.
14. Gupta A, et al. (2008) Neuroendocrine differentiation in the 12T-10 transgenic prostate mouse model mimics endocrine differentiation of pancreatic beta cells. Prostate 68(1):50-60.
15. Rostomily RC, et al. (1997) Expression of neurogenic basic helix-loop-helix genes in primitive neuroectodermal tumors. Cancer Res 57(16):3526-3531.
16. Syder AJ, et al. (2004) A transgenic mouse model of metastatic carcinoma involving transdifferentiation of a gastric epithelial lineage progenitor to a neuroendocrine phenotype. Proc Natl Acad Sci USA 101(13):4471-4476.
17. Ramirez RD, et al. (2004) Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res 64(24):9027-9034.
18. Sato M, et al. (2006) Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res 66(4):2116-2128.
19. Sato M, et al. (2013) Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations. Molec Cancer Res, in press.
20. Kaplan DR, Matsumoto K, Lucarelli E, Thiele CJ; Eukaryotic Signal Transduction Group (1993) Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells. Neuron 11(2):321-331.
21. Liu K, et al. (2011) MiR-124 regulates early neurogenesis in the optic vesicle and forebrain, targeting NeuroD1. Nucleic Acids Res 39(7):2869-2879.
22. Liu Y, Encinas M, Comella JX, Aldea M, Gallego C (2004) Basic helix-loop-helix proteins bind to TrkB and p21(Cip1) promoters linking differentiation and cell cycle arrest in neuroblastoma cells. Mol Cell Biol 24(7):2662-2672.
23. Seki T (2002) Expression patterns of immature neuronal markers PSA-NCAM, CRMP-4 and NeuroD in the hippocampus of young adult and aged rodents. J Neurosci Res 70(3):327-334.
24. Seo S, Lim JW, Yellajoshyula D, Chang LW, Kroll KL (2007) Neurogenin and NeuroD direct transcriptional targets and their regulatory enhancers. EMBOJ26(24):5093-5108.
25. Au CW, et al. (2009) Tyrosine kinase B receptor and BDNF expression in ovarian cancers-effect on cell migration, angiogenesis and clinical outcome. Cancer Lett 281(2):151-161.
26. Douma S, et al. (2004) Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 430(7003):1034-1039.
27. Kupferman ME, et al. (2010) TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma. Oncogene 29(14):2047-2059.
28. Cavallaro U, Niedermeyer J, Fuxa M, Christofori G (2001) N-CAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signalling. Nat Cell Biol 3(7):650-657.
29. Daniloff JK, Chuong CM, Levi G, Edelman GM (1986) Differential distribution of cell adhesion molecules during histogenesis of the chick nervous system. J Neurosci 6(3):739-758.
30. Hoffman S, Friedlander DR, Chuong CM, Grumet M, Edelman GM (1986) Differential contributions of Ng-CAM and N-CAM to cell adhesion in different neural regions. J Cell Biol 103(1):145-158.
31. Vutskits L, et al. (2001) PSA-NCAM modulates BDNF-dependent survival and differentiation of cortical neurons. Eur J Neurosci 13(7):1391-1402.
32. Neptune ER, et al. (2008) Targeted disruption of NeuroD, a proneural basic helix-loop-helix factor, impairs distal lung formation and neuroendocrine morphology in the neonatal lung. J Biol Chem 283(30):21160-21169.
33. Lee JE, et al. (1995) Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein. Science 268(5212):836-844.
34. Kashiwagi K, et al. (2012) Differences of molecular expression mechanisms among neural cell adhesion molecule 1, synaptophysin, and chromogranin A in lung cancer cells. Pathol Int 62(4):232-245.
35. Knapper S, et al. (2006) A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy. Blood 108(10):3262-3270.
36. Thiele CJ, Li Z, McKee AE (2009) On Trk-the TrkB signal transduction pathway is an increasingly important target in cancer biology. Clin Cancer Res 15(19):5962-5967.
37. Kiselyov VV, et al. (2003) Structural basis for a direct interaction between FGFR1 and NCAM and evidence for a regulatory role of ATP. Structure 11(6):691-701.
38. Soroka V, et al. (2003) Structure and interactions of NCAM Ig1-2-3 suggest a novel zipper mechanism for homophilic adhesion. Structure 11(10):1291-1301.
39. Cassens C, et al. (2010) Binding of the receptor tyrosine kinase TrkB to the neural cell adhesion molecule (NCAM) regulates phosphorylation of NCAM and NCAM-dependent neurite outgrowth. J Biol Chem 285(37):28959-28967.
40. Liu ZZ, Zhu LQ, Eide FF (1997) Critical role of TrkB and brain-derived neurotrophic factor in the differentiation and survival of retinal pigment epithelium. J Neurosci 17(22):8749-8755.
41. Luikart BW, et al. (2008) Neurotrophin-dependent dendritic filopodial motility: A convergence on PI3K signaling. J Neurosci 28(27):7006-7012.
42. Sclabas GM, et al. (2005) Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells. Clin Cancer Res 11(2 Pt 1):440-449.
43. Ditlevsen DK, Povlsen GK, Berezin V, Bock E (2008) NCAM-induced intracellular signaling revisited. J Neurosci Res 86(4):727-743.
44. Blackhall FH, Shepherd FA (2007) Small cell lung cancer and targeted therapies. Curr Opin Oncol 19(2):103-108.
45. Lawrence MC, McGlynn K, Park BH, Cobb MH (2005) ERK1/2-dependent activation of transcription factors required for acute and chronic effects of glucose on the insulin gene promoter. J Biol Chem 280(29):26751-26759.
46. Paroo Z, et al. (2004) Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden. Mol Imaging 3(2):117-124.
47. Ding LH, Xie Y, Park S, Xiao G, Story MD (2008) Enhanced identification and biological validation of differential gene expression via Illumina whole-genome expression arrays through the use of the model-based background correction methodology. Nucleic Acids Res 36(10):e58.